These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22764258)

  • 1. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
    Politis M; Giannetti P; Su P; Turkheimer F; Keihaninejad S; Wu K; Waldman A; Malik O; Matthews PM; Reynolds R; Nicholas R; Piccini P
    Neurology; 2012 Aug; 79(6):523-30. PubMed ID: 22764258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
    Sucksdorff M; Rissanen E; Tuisku J; Nuutinen S; Paavilainen T; Rokka J; Rinne J; Airas L
    J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration.
    Gerhard A; Watts J; Trender-Gerhard I; Turkheimer F; Banati RB; Bhatia K; Brooks DJ
    Mov Disord; 2004 Oct; 19(10):1221-6. PubMed ID: 15390000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study.
    Giannetti P; Politis M; Su P; Turkheimer F; Malik O; Keihaninejad S; Wu K; Reynolds R; Nicholas R; Piccini P
    Neurobiol Dis; 2014 May; 65():203-10. PubMed ID: 24508617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.
    Giannetti P; Politis M; Su P; Turkheimer FE; Malik O; Keihaninejad S; Wu K; Waldman A; Reynolds R; Nicholas R; Piccini P
    Brain; 2015 Jan; 138(Pt 1):110-9. PubMed ID: 25416179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial Correlation of Pathology and Perfusion Changes within the Cortex and White Matter in Multiple Sclerosis.
    Mulholland AD; Vitorino R; Hojjat SP; Ma AY; Zhang L; Lee L; Carroll TJ; Cantrell CG; Figley CR; Aviv RI
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):91-96. PubMed ID: 29097413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study.
    Singhal T; O'Connor K; Dubey S; Pan H; Chu R; Hurwitz S; Cicero S; Tauhid S; Silbersweig D; Stern E; Kijewski M; DiCarli M; Weiner HL; Bakshi R
    Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e587. PubMed ID: 31355321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.
    Rissanen E; Virta JR; Paavilainen T; Tuisku J; Helin S; Luoto P; Parkkola R; Rinne JO; Airas L
    J Cereb Blood Flow Metab; 2013 Sep; 33(9):1394-401. PubMed ID: 23695433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
    Rudick RA; Lee JC; Nakamura K; Fisher E
    J Neurol Sci; 2009 Jul; 282(1-2):106-11. PubMed ID: 19100997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
    Calabrese M; Reynolds R; Magliozzi R; Castellaro M; Morra A; Scalfari A; Farina G; Romualdi C; Gajofatto A; Pitteri M; Benedetti MD; Monaco S
    PLoS One; 2015; 10(8):e0135428. PubMed ID: 26267665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial activation correlates with severity in Huntington disease: a clinical and PET study.
    Pavese N; Gerhard A; Tai YF; Ho AK; Turkheimer F; Barker RA; Brooks DJ; Piccini P
    Neurology; 2006 Jun; 66(11):1638-43. PubMed ID: 16769933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
    Debruyne JC; Versijpt J; Van Laere KJ; De Vos F; Keppens J; Strijckmans K; Achten E; Slegers G; Dierckx RA; Korf J; De Reuck JL
    Eur J Neurol; 2003 May; 10(3):257-64. PubMed ID: 12752399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.
    Edison P; Archer HA; Gerhard A; Hinz R; Pavese N; Turkheimer FE; Hammers A; Tai YF; Fox N; Kennedy A; Rossor M; Brooks DJ
    Neurobiol Dis; 2008 Dec; 32(3):412-9. PubMed ID: 18786637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal patterns of cortical thinning in multiple sclerosis.
    Tsagkas C; Chakravarty MM; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Magon S
    Hum Brain Mapp; 2020 Jun; 41(8):2198-2215. PubMed ID: 32067281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
    Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.